Form 4: Solid Biosciences Director Sells Shares for Tax Withholding
Insider Transaction Report
Solid Biosciences Director Ilan Ganot sold 7,205 shares of common stock to cover tax obligations related to restricted stock unit vesting.
Summary
- Ilan Ganot, a Director at Solid Biosciences Inc. (SLDB), sold 7,205 shares of common stock.
- The transaction occurred on February 4, 2026, at a weighted average price of $6.4419 per share.
- This sale was non-discretionary, executed to cover withholding taxes following the vesting of previously granted restricted stock units.
- The sale was made pursuant to a durable automatic sales instruction letter adopted on September 25, 2024.
- Following the transaction, Ilan Ganot beneficially owns 143,962 shares of Solid Biosciences common stock, including direct holdings, indirect holdings through his wife, and shares held by a trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this transaction as neutral, as it is a non-discretionary sale to cover tax obligations related to RSU vesting, a standard practice that does not reflect a change in the insider's investment sentiment.
Industry Context
StockSavvy.ai notes that routine insider sales to cover tax obligations upon RSU vesting are common across all industries and typically do not signal a change in management's outlook on the company's prospects. This transaction is specific to an individual's compensation structure rather than a broader industry trend.
Stakeholder Impact
- Minimal impact on shareholders as this is a routine, non-discretionary sale for tax purposes and does not indicate a change in the director's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 2017-03-03 | Date of the Ilan Ganot 2017 Irrevocable Trust. |
| 2024-09-25 | Date Ms. Ganot adopted the durable automatic sales instruction letter for sell-to-cover election. |
| 2026-02-04 | Date of the reported transaction (sale of common stock). |
| 2026-02-06 | Date the Form 4 was filed. |
Keywords
Solid Biosciences, SLDB, Ilan Ganot, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Director, Equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.